Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-α

TOMITA Shintaro; ISHIBASHI Kei; HASHIMOTO Koichi; SUGINO Takashi; YANAGIDA Tomohiko; KUSHIDA Nobuhiro; SHISHIDO Keiichi; AIKAWA Ken; SATO Yuka; SUZUTANI Tatsuo; YAMAGUCHI Osamu

Art

J-GLOBAL ID：201102286743449232 Reference number：11A0292626

Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-α

SOCS3の抑制はインターフェロンαに対する腎細胞癌の感受性を増大させる

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=11A0292626&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A0292626&from=J-GLOBAL&jstjournalNo=W1423A") }}

Author (11)： , , , , , , , , , ,
Material：
Volume： 102 Issue： 1 Page： 57-63 Publication year： Jan. 2011
JST Material Number： W1423A ISSN： 1347-9032 Document type： Article
Article type：原著論文 Country of issue： Australia (AUS) Language： ENGLISH (EN)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A0292626&from=J-GLOBAL&jstjournalNo=W1423A") }}

Experimental treatment for tumors , Biological function

Reference (29)：

LANDIS, SH. Cancer statistics, 1999. CA Cancer J Clin. 1999, 49, 1, 8-31
MOTZER, RJ. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. N Engl J Med. 2007, 356, 115-124
MOTZER, RJ. Sunitinib efficacy against advanced renal cell carcinoma. J Urol. 2007, 178, 1883-1887
HUDES, G. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med. 2007, 356, 2271-2281
ESCUDIER, B. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma : a randomised, double-blind phase III trial. Lancet. 2007, 370, 2103-2111

ｍore...

, , ,

Return to Previous Page